Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Trials & Approvals

Updates on new clinical tirals being performed in China, trial updates and drug approvals...

EpimAb Files US/China INDs for Bispecific Cancer Antibody
CARsgen Reports Positive Results from CAR-T Trial in Solid Tumor Cancers
Innovent Approved for China Trial of CD47 I-O Drug
Chi-Med OK'd for China Use of Fruquintinib, its First Drug Approval
Eisai Announces China Approval for Liver Cancer Treatment
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Other Events

www.chinatrialsevent.com

Shanghai,China

November 7–9, 2018

ChinaBio members can get a 20% discount with the promotion code"chinabio18"